Australia Intravenous Solutions Market Size & Outlook
Australia intravenous solutions market, 2018-2030 (US$M)
Related Markets
Australia intravenous solutions market highlights
- The Australia intravenous solutions market generated a revenue of USD 177.0 million in 2023 and is expected to reach USD 312.3 million by 2030.
- The Australia market is expected to grow at a CAGR of 8.5% from 2024 to 2030.
- In terms of segment, total parenteral nutrition was the largest revenue generating product in 2023.
- Total Parenteral Nutrition is the most lucrative product segment registering the fastest growth during the forecast period.
Intravenous solutions market data book summary
| Market revenue in 2023 | USD 177.0 million |
| Market revenue in 2030 | USD 312.3 million |
| Growth rate | 8.5% (CAGR from 2023 to 2030) |
| Largest segment | Total parenteral nutrition |
| Fastest growing segment | Total Parenteral Nutrition |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Total Parenteral Nutrition, Peripheral Parenteral Nutrition |
| Key market players worldwide | Fresenius SE & Co KGaA, Fresenius Kabi, Pfizer Inc, Otsuka Pharmaceutical, Baxter International Inc, B. Braun, JW Life Sciences, CSL Ltd |
Other key industry trends
- In terms of revenue, Australia accounted for 1.4% of the global intravenous solutions market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Asia Pacific, China intravenous solutions market is projected to lead the regional market in terms of revenue in 2030.
- India is the fastest growing regional market in Asia Pacific and is projected to reach USD 893.7 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Intravenous Solutions Market Scope
Intravenous Solutions Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Australia intravenous solutions market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to intravenous solutions market will help companies and investors design strategic landscapes.
Total parenteral nutrition was the largest segment with a revenue share of 65.99% in 2023. Horizon Databook has segmented the Australia intravenous solutions market based on total parenteral nutrition, peripheral parenteral nutrition covering the revenue growth of each sub-segment from 2018 to 2030.
The Australian government is investing in the healthcare ecosystem to strengthen patient care. A favorable political environment and supporting budgetary policies will aid in developing key ancillaries, which is expected to drive the IV solution market during the forecast period.
Reasons to subscribe to Australia intravenous solutions market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Australia intravenous solutions market databook
-
Our clientele includes a mix of intravenous solutions market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Australia intravenous solutions market , including forecasts for subscribers. This country databook contains high-level insights into Australia intravenous solutions market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Australia intravenous solutions market size, by product, 2018-2030 (US$M)
Australia Intravenous Solutions Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
